Wright Andrew D, Turk Thomas M T, Nagar Michael S, Phelan Michael W, Perry Kent T
Department of Urology, Loyola University Medical Center, Maywood, Illinois 60185, USA.
J Endourol. 2007 Dec;21(12):1493-6. doi: 10.1089/end.2007.9850.
Laparoscopic renal cryoablation is an emerging minimally invasive management option for T(1) renal lesions. In an analysis of patients treated with laparoscopic cryoablation for renal lesions, our objective was to compare the treatment outcomes in patients with exophytic/partially exophytic and endophytic (peripheral but completely intrarenal) lesions.
We retrospectively reviewed medical records of 32 consecutive patients with anterior renal lesions who were treated with laparoscopic renal cryoablation between 2003 and 2005. Biopsy samples were obtained from the majority of lesions intraoperatively. The lesions were managed with 17 gauge needles and two freeze/thaw cycles. Follow-up was performed with CT scans at 3, 6, and 12 months, and then yearly. Treatment failures were defined as continued enhancement on CT or growth of the lesion. Statistical analysis was performed using t-test, correlative, and multiple regression analysis.
A total of 35 lesions in 32 patients were identified. Median lesion size was 1.9 cm. Median age was 67 years, with most patients having significant comorbidities. The median preoperative and postoperative creatinine level was 1.3 and 1.5 mg/dL (P = 0.38). Of the biopsy samples from 27 of 35 lesions, 18 showed renal cell carcinoma, 5 were found to be benign, and findings from 4 were inconclusive. Three lesions were completely endophytic. The median follow-up was 18 months, with treatment failures noted in 2 of 35 lesions (6%), both of which were endophytic (P < 0.0001). Multivariate analysis revealed that only the endophytic status of a lesion was a predictor of failure (P < 0.05). These were lesions that relied entirely on intraoperative ultrasonography for targeting, which suggests that failure was a technical error.
Experience with renal cryoablation is still evolving. Our series further defines the role of laparoscopic renal cryoablation and its limitations in managing peripheral endophytic tumors. Completely endophytic lesions have a significantly higher risk of treatment failure. Reliance solely on intraoperative ultrasonography with no visual cues is a risk factor for treatment failure.
腹腔镜肾冷冻消融术是一种新兴的用于治疗 T(1)期肾病变的微创治疗方法。在一项对接受腹腔镜肾冷冻消融术治疗肾病变患者的分析中,我们的目的是比较外生性/部分外生性病变和内生性(位于肾周边但完全位于肾内)病变患者的治疗结果。
我们回顾性分析了 2003 年至 2005 年间连续 32 例接受腹腔镜肾冷冻消融术治疗的前位肾病变患者的病历。大多数病变在术中获取了活检样本。病变采用 17 号针及两个冻融周期进行处理。在术后 3 个月、6 个月和 12 个月时进行 CT 扫描随访,之后每年进行一次。治疗失败定义为 CT 上病变持续强化或增大。采用 t 检验、相关性分析和多元回归分析进行统计学分析。
32 例患者共发现 35 个病变。病变中位大小为 1.9 cm。中位年龄为 67 岁,大多数患者有明显的合并症。术前和术后肌酐水平中位数分别为 1.3 和 1.5 mg/dL(P = 0.38)。35 个病变中的 27 个病变的活检样本中,18 个显示为肾细胞癌,5 个为良性,4 个结果不明确。3 个病变完全为内生性。中位随访时间为 18 个月,35 个病变中有 2 个(6%)出现治疗失败,均为内生性病变(P < 0.0001)。多因素分析显示,仅病变的内生性状态是失败的预测因素(P < 0.05)。这些病变完全依赖术中超声进行定位,这提示失败是技术失误所致。
肾冷冻消融术的经验仍在不断积累。我们的系列研究进一步明确了腹腔镜肾冷冻消融术的作用及其在处理周边内生性肿瘤方面的局限性。完全内生性病变治疗失败的风险显著更高。单纯依赖术中超声且无视觉线索是治疗失败的一个危险因素。